{"id":"https://openalex.org/W2139707889","doi":"https://doi.org/10.1158/1535-7163.mct-13-0011","title":"Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma","display_name":"Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma","alternate_titles":[],"publication_year":2013,"publication_date":"2013-07-01","ids":{"openalex":"https://openalex.org/W2139707889","doi":"https://doi.org/10.1158/1535-7163.mct-13-0011","mag":"2139707889","pmid":"https://pubmed.ncbi.nlm.nih.gov/23645591"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-13-0011","doi":"https://doi.org/10.1158/1535-7163.mct-13-0011","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-13-0011","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139707889"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083061830","display_name":"Matteo Salvatore Carlino","orcid":"https://orcid.org/0000-0002-7861-4104","observed_orcids":["https://orcid.org/0000-0002-7861-4104"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I78757542","display_name":"University of Newcastle Australia","ror":"https://ror.org/00eae9z71","country_code":"AU","type":"education","lineage":["https://openalex.org/I78757542"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Matteo S. Carlino","raw_affiliation_strings":["Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705","https://openalex.org/I4210118383","https://openalex.org/I78757542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037264193","display_name":"Kavitha Gowrishankar","orcid":"https://orcid.org/0000-0002-8616-6727","observed_orcids":["https://orcid.org/0000-0002-8616-6727"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I78757542","display_name":"University of Newcastle Australia","ror":"https://ror.org/00eae9z71","country_code":"AU","type":"education","lineage":["https://openalex.org/I78757542"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kavitha Gowrishankar","raw_affiliation_strings":["Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705","https://openalex.org/I4210118383","https://openalex.org/I78757542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038576019","display_name":"Catherine A.B. Saunders","orcid":"https://orcid.org/0000-0001-6928-7378","observed_orcids":["https://orcid.org/0000-0001-6928-7378"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I78757542","display_name":"University of Newcastle Australia","ror":"https://ror.org/00eae9z71","country_code":"AU","type":"education","lineage":["https://openalex.org/I78757542"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Catherine A.B. Saunders","raw_affiliation_strings":["Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705","https://openalex.org/I4210118383","https://openalex.org/I78757542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090820450","display_name":"Gulietta M. Pupo","orcid":"https://orcid.org/0000-0002-8556-4002","observed_orcids":["https://orcid.org/0000-0002-8556-4002"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I78757542","display_name":"University of Newcastle Australia","ror":"https://ror.org/00eae9z71","country_code":"AU","type":"education","lineage":["https://openalex.org/I78757542"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gulietta M. Pupo","raw_affiliation_strings":["Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705","https://openalex.org/I4210118383","https://openalex.org/I78757542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040852944","display_name":"Stephanie Snoyman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I78757542","display_name":"University of Newcastle Australia","ror":"https://ror.org/00eae9z71","country_code":"AU","type":"education","lineage":["https://openalex.org/I78757542"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephanie Snoyman","raw_affiliation_strings":["Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705","https://openalex.org/I4210118383","https://openalex.org/I78757542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072813429","display_name":"Xu Dong Zhang","orcid":"https://orcid.org/0000-0001-9457-8003","observed_orcids":["https://orcid.org/0000-0001-9457-8003"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I78757542","display_name":"University of Newcastle Australia","ror":"https://ror.org/00eae9z71","country_code":"AU","type":"education","lineage":["https://openalex.org/I78757542"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xu Dong Zhang","raw_affiliation_strings":["Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705","https://openalex.org/I4210118383","https://openalex.org/I78757542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081462567","display_name":"Robyn P.M. Saw","orcid":"https://orcid.org/0000-0002-3354-806X","observed_orcids":["https://orcid.org/0000-0002-3354-806X"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I78757542","display_name":"University of Newcastle Australia","ror":"https://ror.org/00eae9z71","country_code":"AU","type":"education","lineage":["https://openalex.org/I78757542"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robyn Saw","raw_affiliation_strings":["Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705","https://openalex.org/I4210118383","https://openalex.org/I78757542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060693295","display_name":"Therese M. Becker","orcid":"https://orcid.org/0000-0002-5636-9902","observed_orcids":["https://orcid.org/0000-0002-5636-9902"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I78757542","display_name":"University of Newcastle Australia","ror":"https://ror.org/00eae9z71","country_code":"AU","type":"education","lineage":["https://openalex.org/I78757542"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Therese M. Becker","raw_affiliation_strings":["Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705","https://openalex.org/I4210118383","https://openalex.org/I78757542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062978331","display_name":"Richard F. Kefford","orcid":"https://orcid.org/0000-0001-9251-9229","observed_orcids":["https://orcid.org/0000-0001-9251-9229"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I78757542","display_name":"University of Newcastle Australia","ror":"https://ror.org/00eae9z71","country_code":"AU","type":"education","lineage":["https://openalex.org/I78757542"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard F. Kefford","raw_affiliation_strings":["Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705","https://openalex.org/I4210118383","https://openalex.org/I78757542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070576000","display_name":"Georgina Venetia Long","orcid":"https://orcid.org/0000-0001-8894-3545","observed_orcids":["https://orcid.org/0000-0001-8894-3545"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I78757542","display_name":"University of Newcastle Australia","ror":"https://ror.org/00eae9z71","country_code":"AU","type":"education","lineage":["https://openalex.org/I78757542"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Georgina V. Long","raw_affiliation_strings":["Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705","https://openalex.org/I4210118383","https://openalex.org/I78757542"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069277796","display_name":"Helen Rizos","orcid":"https://orcid.org/0000-0002-2094-9198","observed_orcids":["https://orcid.org/0000-0002-2094-9198"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I78757542","display_name":"University of Newcastle Australia","ror":"https://ror.org/00eae9z71","country_code":"AU","type":"education","lineage":["https://openalex.org/I78757542"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Helen Rizos","raw_affiliation_strings":["Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; Departments of 2Medical Oncology and 3Nuclear medicine PET and Ultrasound, Westmead Hospital; 4Melanoma Institute Australia, Sydney; and 5Immunology and Oncology Unit, Newcastle University, New South Wales, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705","https://openalex.org/I4210118383","https://openalex.org/I78757542"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.5572,"has_fulltext":false,"cited_by_count":85,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94856249,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"12","issue":"7","first_page":"1332","last_page":"1342"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8090000152587891},{"id":"https://openalex.org/keywords/braf-mutant-melanoma","display_name":"BRAF-mutant melanoma","score":0.7540000081062317},{"id":"https://openalex.org/keywords/mapk-inhibitors","display_name":"MAPK inhibitors","score":0.7670000195503235},{"id":"https://openalex.org/keywords/dabrafenib","display_name":"dabrafenib","score":0.8389999866485596},{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.9760000109672546},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.8190000057220459},{"id":"https://openalex.org/keywords/cyclin-d1","display_name":"cyclin D1","score":0.777999997138977},{"id":"https://openalex.org/keywords/retinoblastoma-protein","display_name":"retinoblastoma protein","score":0.7429999709129333},{"id":"https://openalex.org/keywords/s-phase-inhibition","display_name":"S-phase inhibition","score":0.902999997138977},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C2778472372","wikidata":"https://www.wikidata.org/wiki/Q7833138","display_name":"Trametinib","level":4,"score":0.8354145884513855},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.830264687538147},{"id":"https://openalex.org/C2778830669","wikidata":"https://www.wikidata.org/wiki/Q3011604","display_name":"Dabrafenib","level":5,"score":0.7352469563484192},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.7049009799957275},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6288072466850281},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.5822839140892029},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.545485258102417},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5246591567993164},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4623684883117676},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.46057629585266113},{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.34828466176986694},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3114628791809082},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.15097570419311523},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07021546363830566}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010091","descriptor_name":"Oximes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010091","descriptor_name":"Oximes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011744","descriptor_name":"Pyrimidinones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020929","descriptor_name":"Mitogen-Activated Protein Kinase Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D020929","descriptor_name":"Mitogen-Activated Protein Kinase Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.mct-13-0011","doi":"https://doi.org/10.1158/1535-7163.mct-13-0011","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-13-0011","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:23645591","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23645591","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Case Reports"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.897.3660","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.897.3660","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://mct.aacrjournals.org/content/12/7/1332.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320966","display_name":"University of Sydney","ror":"https://ror.org/0384j8v12"},{"id":"https://openalex.org/F4320329041","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W1550040515","https://openalex.org/W1966558069","https://openalex.org/W1980906814","https://openalex.org/W1988379285","https://openalex.org/W1990376228","https://openalex.org/W1997795769","https://openalex.org/W2014881369","https://openalex.org/W2017187984","https://openalex.org/W2019607817","https://openalex.org/W2024085992","https://openalex.org/W2030039510","https://openalex.org/W2032211985","https://openalex.org/W2043058822","https://openalex.org/W2053473615","https://openalex.org/W2055624262","https://openalex.org/W2058261026","https://openalex.org/W2058390096","https://openalex.org/W2080626878","https://openalex.org/W2098216041","https://openalex.org/W2100614336","https://openalex.org/W2101824720","https://openalex.org/W2106494998","https://openalex.org/W2106543129","https://openalex.org/W2115504770","https://openalex.org/W2119505091","https://openalex.org/W2122376569","https://openalex.org/W2125485324","https://openalex.org/W2128208856","https://openalex.org/W2128542677","https://openalex.org/W2129931005","https://openalex.org/W2134490812","https://openalex.org/W2136474966","https://openalex.org/W2137086207","https://openalex.org/W2141674733","https://openalex.org/W2142865455","https://openalex.org/W2155381255","https://openalex.org/W2155461614","https://openalex.org/W2156078931","https://openalex.org/W2161018320","https://openalex.org/W2165845591","https://openalex.org/W2166262263","https://openalex.org/W2166595100","https://openalex.org/W2168143310","https://openalex.org/W2231248733","https://openalex.org/W2591544462","https://openalex.org/W2598403415","https://openalex.org/W2604163360"],"related_works":["https://openalex.org/W2724458594","https://openalex.org/W2947157850","https://openalex.org/W2401574182","https://openalex.org/W2052781279","https://openalex.org/W2969491369","https://openalex.org/W1990511191","https://openalex.org/W1980906814","https://openalex.org/W2009228205","https://openalex.org/W3114840729"],"abstract_inverted_index":{"Inhibitors":[0],"of":[1,18,27,35,40,71,83,108,119,149,160,192,228,240],"the":[2,16,33,81,106,117,147,226,238],"mitogen-activated":[3],"protein":[4],"kinases":[5],"(MAPK),":[6],"BRAF,":[7],"and":[8,51,105,167,180,195,217,230,236],"MAP-ERK":[9],"kinase":[10],"(MEK)":[11],"induce":[12],"tumor":[13,204],"regression":[14],"in":[15,64,116,122,134,173,177,215],"majority":[17],"patients":[19],"with":[20,38,94,170,189,211],"BRAF-mutant":[21],"metastatic":[22],"melanoma.":[23],"The":[24],"clinical":[25,103,241],"benefit":[26,43],"MAPK":[28,95,129,165,174,209,218],"inhibitors":[29,96,110,130,232],"is":[30],"restricted":[31],"by":[32,46,138],"development":[34,239],"acquired":[36,135],"resistance":[37],"half":[39],"those":[41],"who":[42],"having":[44],"progressed":[45],"6":[47],"to":[48,80,112,143,164,208,243],"7":[49],"months":[50],"long-term":[52],"responders":[53],"uncommon.":[54],"There":[55],"remains":[56],"no":[57],"agreed":[58],"treatment":[59,93],"strategy":[60],"on":[61,75],"disease":[62,73,87,98,120,234],"progression":[63,74,99,121,235],"these":[65,109,150],"patients.":[66,124],"Without":[67],"published":[68],"evidence,":[69],"fears":[70],"accelerated":[72],"inhibitor":[76],"withdrawal":[77,107],"have":[78],"led":[79,111],"continuation":[82,227],"drugs":[84],"beyond":[85,97],"formal":[86],"progression.":[88],"We":[89,125],"now":[90],"show":[91,127],"that":[92,128],"can":[100],"provide":[101,222],"significant":[102],"benefit,":[104],"a":[113,156,171,223],"marked":[114],"increase":[115],"rate":[118,159],"two":[123],"also":[126,187,206],"retain":[131],"partial":[132],"activity":[133],"resistant":[136,153,203],"melanoma":[137,199],"examining":[139],"drug-resistant":[140],"clones":[141],"generated":[142,201],"dabrafenib,":[144],"trametinib,":[145],"or":[146],"combination":[148],"drugs.":[151],"All":[152],"sublines":[154],"displayed":[155],"markedly":[157],"slower":[158],"proliferation":[161,216],"when":[162],"exposed":[163],"inhibitors,":[166],"this":[168,245],"coincided":[169],"reduction":[172],"signaling,":[175],"decrease":[176],"bromodeoxyuridine":[178],"incorporation,":[179],"S-phase":[181],"inhibition.":[182],"This":[183],"cytostatic":[184],"effect":[185],"was":[186],"associated":[188],"diminished":[190],"levels":[191],"cyclin":[193],"D1":[194],"p-pRb.":[196],"Two":[197],"short-term":[198],"cultures":[200],"from":[202],"biopsies":[205],"responded":[207],"inhibition,":[210],"comparable":[212],"inhibitory":[213],"changes":[214],"signaling.":[219],"These":[220],"data":[221],"rationale":[224],"for":[225],"BRAF":[229],"MEK":[231],"after":[233],"support":[237],"trials":[242],"examine":[244],"strategy.":[246]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139707889","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":15},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
